Tom Ferrey

Background

About Tom Ferrey

I am a Clinical Trial Manager with extensive experience in the Biopharmaceutical industry. I have experience in Phase I-IV drug development—spanning sponsor, imaging vendor, and site levels. As a collaborative leader with strong cross-functional communication skills, I specialize in aligning stakeholders including CROs, vendors, investigators, sites, and internal teams to deliver high-quality, efficient studies. I bring broad therapeutic expertise across immunology, oncology, neurology (CNS), virology, endocrinology, rheumatology, cardiology, inflammation, women’s health, and rare disease, with a proven track record of managing complex global trials. I am passionate about advancing new therapies for patients through science, technology, and teamwork. At Gilead Sciences, I was proud to contribute to four major approvals: three expanded indications for the HIV blockbuster Biktarvy (pregnancy, HIV/HBV co-infection, and pre-existing resistance), and an outpatient indication for Veklury (remdesivir) for COVID-19.